Literature DB >> 34991121

Using Longitudinally Linked Data to Measure Severe Maternal Morbidity.

Eugene R Declercq1, Howard J Cabral, Xiaohui Cui, Chia-Ling Liu, Ndidiamaka Amutah-Onukagha, Elysia Larson, Audra Meadows, Hafsatou Diop.   

Abstract

OBJECTIVE: To assess whether application of a standard algorithm to hospitalizations in the prenatal and postpartum (42 days) periods increases identification of severe maternal morbidity (SMM) beyond analysis of only the delivery event.
METHODS: We performed a retrospective cohort study using data from the PELL (Pregnancy to Early Life Longitudinal) database, a Massachusetts population-based data system that links records from birth certificates to delivery hospital discharge records and nonbirth hospital records for all birthing individuals. We included deliveries from January 1, 2009, to December 31, 2018, distinguishing between International Classification of Diseases Ninth (ICD-9) and Tenth Revision (ICD-10) coding. We applied the modified Centers for Disease Control and Prevention algorithm for SMM used by the Alliance for Innovation on Maternal Health to hospitalizations across the antenatal period through 42 days postpartum. Morbidity was examined both with and without blood transfusion.
RESULTS: Overall, 594,056 deliveries were included in the analysis, and 3,947 deliveries met criteria for SMM at delivery without transfusion and 9,593 with transfusion for aggregate rates of 150.1 (95% CI 146.7-153.5) using ICD-9 codes and 196.6 (95% CI 189.5-203.7) using ICD-10 codes per 10,000 deliveries. Severe maternal morbidity at birth increased steadily across both ICD-9 and ICD-10 from 129.4 in 2009 (95% CI 126.2-132.6) using ICD-9 to 214.3 per 10,000 (95% CI 206.9-221.8) in 2018 using ICD-10. Adding prenatal and postpartum hospitalizations increased cases by 21.9% under both ICD-9 and ICD-10, resulting in a 2018 rate of 258.7 per 10,000 (95% CI 250.5-266.9). The largest increase in detected morbidity in the prenatal or postpartum time period was attributed to sepsis cases.
CONCLUSION: Inclusion of prenatal and postpartum hospitalizations in the identification of SMM resulted in increased ascertainment of morbid events. These results suggest a need to ensure surveillance of care quality activities beyond the birth event.
Copyright © 2022 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34991121      PMCID: PMC8820447          DOI: 10.1097/AOG.0000000000004641

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  16 in total

1.  Measuring severe maternal morbidity: validation of potential measures.

Authors:  Elliott K Main; Anisha Abreo; Jennifer McNulty; William Gilbert; Colleen McNally; Debra Poeltler; Katarina Lanner-Cusin; Douglas Fenton; Theresa Gipps; Kathryn Melsop; Naomi Greene; Jeffrey B Gould; Sarah Kilpatrick
Journal:  Am J Obstet Gynecol       Date:  2015-11-12       Impact factor: 8.661

2.  Pregnancy-Associated Death in Utah: Contribution of Drug-Induced Deaths.

Authors:  Marcela C Smid; Nicole M Stone; Laurie Baksh; Michelle P Debbink; Brett D Einerson; Michael W Varner; Adam J Gordon; Erin A S Clark
Journal:  Obstet Gynecol       Date:  2019-06       Impact factor: 7.661

3.  Severe Maternal Morbidity at Delivery and Risk of Hospital Encounters Within 6 Weeks and 1 Year Postpartum.

Authors:  Elizabeth M Harvey; Saifuddin Ahmed; Susan E Manning; Hafsatou Diop; Cynthia Argani; Donna M Strobino
Journal:  J Womens Health (Larchmt)       Date:  2017-09-27       Impact factor: 2.681

4.  Severe maternal morbidity among delivery and postpartum hospitalizations in the United States.

Authors:  William M Callaghan; Andreea A Creanga; Elena V Kuklina
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

5.  Creating the first national linked dataset on perinatal and maternal outcomes in Australia: Methods and challenges.

Authors:  Seong L Cheah; Vanessa L Scarf; Chris Rossiter; Charlene Thornton; Caroline S E Homer
Journal:  J Biomed Inform       Date:  2019-03-16       Impact factor: 6.317

6.  Racial and Ethnic Disparities in Maternal and Infant Outcomes Among Opioid-Exposed Mother-Infant Dyads in Massachusetts (2017-2019).

Authors:  Mary Peeler; Munish Gupta; Patrice Melvin; Allison S Bryant; Hafsatou Diop; Ronald Iverson; Katherine Callaghan; Elisha M Wachman; Rachana Singh; Mary Houghton; Shelly F Greenfield; Davida M Schiff
Journal:  Am J Public Health       Date:  2020-10-15       Impact factor: 9.308

7.  Defining a conceptual framework for near-miss maternal morbidity.

Authors:  Stacie E Geller; Deborah Rosenberg; Suzanne M Cox; Sarah Kilpatrick
Journal:  J Am Med Womens Assoc (1972)       Date:  2002

Review 8.  Severe Maternal or Near Miss Morbidity: Implications for Public Health Surveillance and Clinical Audit.

Authors:  Elena V Kuklina; David A Goodman
Journal:  Clin Obstet Gynecol       Date:  2018-06       Impact factor: 2.190

9.  Race and Ethnicity, Medical Insurance, and Within-Hospital Severe Maternal Morbidity Disparities.

Authors:  Elizabeth A Howell; Natalia N Egorova; Teresa Janevic; Michael Brodman; Amy Balbierz; Jennifer Zeitlin; Paul L Hebert
Journal:  Obstet Gynecol       Date:  2020-02       Impact factor: 7.623

10.  Vital Signs: Pregnancy-Related Deaths, United States, 2011-2015, and Strategies for Prevention, 13 States, 2013-2017.

Authors:  Emily E Petersen; Nicole L Davis; David Goodman; Shanna Cox; Nikki Mayes; Emily Johnston; Carla Syverson; Kristi Seed; Carrie K Shapiro-Mendoza; William M Callaghan; Wanda Barfield
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-05-10       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.